SSR1
Translocon-associated protein subunit alpha
Also known as: SSRA_HUMAN, TRAPA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P43307
- Gene
- SSR1
- Ensembl
- ENSG00000124783
- Chromosome
- 6
- Canonical length
- 286 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
The signal sequence receptor (SSR) is a glycosylated endoplasmic reticulum (ER) membrane receptor associated with protein translocation across the ER membrane. The SSR consists of 2 subunits, a 34-kD glycoprotein encoded by this gene and a 22-kD glycoprotein. This gene generates several mRNA species as a result of complex alternative polyadenylation. This gene is unusual in that it utilizes arrays of polyA signal sequences that are mostly non-canonical. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
Canonical amino-acid sequenceUniProt
286 residues, UniProt reviewed canonical sequence.
>P43307|SSR1
1 MRLLPRLLLL LLLVFPATVL FRGGPRGLLA VAQDLTEDEE TVEDSIIEDE DDEAEVEEDE
61 PTDLVEDKEE EDVSGEPEAS PSADTTILFV KGEDFPANNI VKFLVGFTNK GTEDFIVESL
121 DASFRYPQDY QFYIQNFTAL PLNTVVPPQR QATFEYSFIP AEPMGGRPFG LVINLNYKDL
181 NGNVFQDAVF NQTVTVIERE DGLDGETIFM YMFLAGLGLL VIVGLHQLLE SRKRKRPIQK
241 VEMGTSSQND VDMSWIPQET LNQINKASPR RLPRKRAQKR SVGSDELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SSR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 96 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 96 nTPM
- liver: 89 nTPM
- appendix: 84 nTPM
- cervix: 83 nTPM
- thyroid gland: 79 nTPM
- tonsil: 79 nTPM
Single-cell type
- extravillous trophoblasts: 279 nCPM
- plasma cells: 277 nCPM
- esophageal suprabasal cells: 218 nCPM
- parietal cells: 209 nCPM
- kupffer cells: 197 nCPM
- gastric progenitor cells: 196 nCPM
Immune cell
- total PBMC: 215 nTPM
- myeloid DC: 200 nTPM
- classical monocyte: 170 nTPM
- basophil: 146 nTPM
- plasmacytoid DC: 140 nTPM
- intermediate monocyte: 122 nTPM
Brain region
- choroid plexus: 89 nTPM
- white matter: 83 nTPM
- hypothalamus: 75 nTPM
- thalamus: 74 nTPM
- medulla oblongata: 74 nTPM
- midbrain: 67 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.55
- gnomAD pLI
- 0.27
- gnomAD missense Z
- 1.45
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Translocon-associated protein (TRAP), alpha subunit
- Translocon-associated protein (TRAP), alpha subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SSR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SSR1 as an antibody target. Whether an autoantibody or antibody against SSR1 could matter depends on whether native SSR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SSR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SSR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...